Hebei Medical University-Galway University Stem Cell Research Center, Hebei Medical University, Shijiazhuang, 050017, Hebei Province, China.
Hebei Research Center for Stem Cell Medical Translational Engineering, Shijiazhuang, 050017, Hebei Province, China.
Stem Cell Res Ther. 2024 Mar 5;15(1):67. doi: 10.1186/s13287-024-03655-x.
BACKGROUND: Spinal cord injury (SCI) is a serious clinical condition that has pathological changes such as increased neuroinflammation and nerve tissue damage, which eventually manifests as fibrosis of the injured segment and the development of a spinal cord cavity leading to loss of function. Cell-based therapy, such as mesenchymal stem cells (MSCs) and neural stem cells (NSCs) are promising treatment strategies for spinal cord injury via immunological regulation and neural replacement respectively. However, therapeutic efficacy is rare reported on combined transplantation of MSC and NSC in acute mice spinal cord injury even the potential reinforcement might be foreseen. Therefore, this study was conducted to investigate the safety and efficacy of co-transplanting of MSC and NSC sheets into an SCI mice model on the locomotor function and pathological changes of injured spinal cord. METHODS: To evaluate the therapeutic effects of combination cells, acute SCI mice model were established and combined transplantation of hiPSC-NSCs and hMSCs into the lesion site immediately after the injury. Basso mouse scale was used to perform the open-field tests of hind limb motor function at days post-operation (dpo) 1, 3, 5, and 7 after SCI and every week after surgery. Spinal cord and serum samples were collected at dpo 7, 14, and 28 to detect inflammatory and neurotrophic factors. Hematoxylin-eosin (H&E) staining, masson staining and transmission electron microscopy were used to evaluate the morphological changes, fibrosis area and ultrastructure of the spinal cord. RESULT: M&N transplantation reduced fibrosis formation and the inflammation level while promoting the secretion of nerve growth factor and brain-derived neurotrophic factor. We observed significant reduction in damaged tissue and cavity area, with dramatic improvement in the M&N group. Compared with the Con group, the M&N group exhibited significantly improved behaviors, particularly limb coordination. CONCLUSION: Combined transplantation of hiPSC-NSC and hMSC could significantly ameliorate neuroinflammation, promote neuroregeneration, and decrease spinal fibrosis degree in safe and effective pattern, which would be indicated as a novel potential cell treatment option.
背景:脊髓损伤(SCI)是一种严重的临床病症,其病理变化包括神经炎症增加和神经组织损伤,最终表现为损伤节段的纤维化和脊髓空洞的发展,导致功能丧失。基于细胞的治疗方法,如间充质干细胞(MSCs)和神经干细胞(NSCs),通过免疫调节和神经替代分别为脊髓损伤提供了有前途的治疗策略。然而,即使可以预见潜在的增强作用,在急性 SCI 小鼠模型中联合移植 MSC 和 NSC 的治疗效果也很少有报道。因此,本研究旨在探讨 MSC 和 NSC 片联合移植入急性 SCI 小鼠模型对损伤脊髓的运动功能和病理变化的安全性和疗效。
方法:为了评估联合细胞的治疗效果,在损伤后立即将 hiPSC-NSC 和 hMSC 联合移植到损伤部位,建立急性 SCI 小鼠模型。术后第 1、3、5 和 7 天以及术后每周使用 Basso 小鼠量表进行后肢运动功能的旷场测试。术后第 7、14 和 28 天收集脊髓和血清样本,检测炎症和神经营养因子。苏木精-伊红(H&E)染色、Masson 染色和透射电镜用于评估脊髓的形态学变化、纤维化面积和超微结构。
结果:M&N 移植减少了纤维化形成和炎症水平,同时促进了神经生长因子和脑源性神经营养因子的分泌。我们观察到 M&N 组损伤组织和空洞面积明显减少,功能明显改善。与 Con 组相比,M&N 组的行为明显改善,特别是肢体协调性。
结论:hiPSC-NSC 和 hMSC 的联合移植可以显著改善神经炎症,促进神经再生,并以安全有效的方式降低脊髓纤维化程度,这将是一种新的潜在细胞治疗选择。
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2025-6-15
Stem Cell Res Ther. 2021-3-11
Arch Ital Urol Androl. 2025-6-30
Cochrane Database Syst Rev. 2012-11-14
Stem Cell Res Ther. 2024-12-18
Oxid Med Cell Longev. 2022
Signal Transduct Target Ther. 2022-8-6